https://orcid.org/0000-0003-0809-901X
References
- Kone S Revising global indicative wastage rates: a WHO initiative for better planning and forecasting of vaccine supply needs. [Concept Note]. 8 Apr 2019. https://www.who.int/docs/default-source/immunization/tools/revising-wastage-concept-note.pdf?sfvrsn=30e43557_4
- Akbarian M, Chen SH. Instability challenges and stabilization strategies of pharmaceutical proteins. Pharmaceutics. 2022;14(11):2533. doi: 10.3390/pharmaceutics14112533
- Ohtake S, Kita Y, Arakawa T. Interactions of formulation excipients with proteins in solution and in the dried state. Adv Drug Deliv Rev. 2011;63(13):1053–1073. doi: 10.1016/j.addr.2011.06.011
- Vaccines licensed for use in the United States. [internet]. (WA) D.C: The United States Food and Drug Administration. [cited 2023 Oct. 10]. Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states
- Kim NA, Hada S, Thapa R, et al. Arginine as a protein stabilizer and destabilizer in liquid formulations. Int J Pharm. 2016;513(1–2):26–37. doi: 10.1016/j.ijpharm.2016.09.003
- Katz JS, Chou DK, Christian TR, et al. Emerging challenges and innovations in surfactant-mediated stabilization of biologic formulations. J Pharm Sci. 2022;111(4):919–932. doi: 10.1016/j.xphs.2021.12.002
- Dumpa N, Goel K, Guo Y, et al. Stability of vaccines. AAPS Pharm Sci Tech. 2019;20(2):42. doi: 10.1208/s12249-018-1254-2
- Nail SL, Jiang S, Chongprasert S, et al. Fundamentals of freeze-drying. Pharm Biotechnol. 2002;14:281–360. doi: 10.1007/978-1-4615-0549-5_6
- Flood A, Estrada M, McAdams D, et al. Development of a freeze-dried, heat-stable influenza subunit vaccine formulation. PLoS One. 2016;11(11):e0164692. doi: 10.1371/journal.pone.0164692
- Gomez M, Vehring R. Spray drying and particle engineering in dosage form design for global vaccines. J Aerosol Med Pulm Drug Deliv. 2022;35(3):121–138. doi: 10.1089/jamp.2021.0056
- Bajrovic I, Schafer SC, Romanovicz DK, et al. Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature. Sci Adv. 2020;6(10):eaau4819. doi: 10.1126/sciadv.aau4819
- Ameri M, Ao Y, Lewis H. Formulation approach that enables the coating of a stable influenza vaccine on a transdermal microneedle patch. AAPS Pharm Sci Tech. 2021;22(5):175. doi: 10.1208/s12249-021-02044-4
- Lazarus JV, Abdool Karim SS, van Selm L, et al. COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps. BMJ Glob Health. 2022;7(4):e009010. doi: 10.1136/bmjgh-2022-009010
- Gairola S, Bonde P, Sharma P, et al. Stability of lyophilized meningococcal a conjugate vaccine, (MenAfrivac™) at elevated temperatures to support controlled temperature chain (CTC) claim. Biologicals. 2023;83:101698. doi: 10.1016/j.biologicals.2023.101698
- Vander Straeten A, Sarmadi M, Daristotle JL, et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines [published online ahead of print]. Nat Biotechnol. 2023. doi: 10.1038/s41587-023-01774-z